Donate Now
  • What We've Learned
How can we tell if Ankylosing Spondylitis care is being given according to recommendations?
arc_placeholder_new
Scientific Study Title:
Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies.
Start Date:
  • June 2012
End Date:
  • July 2014
Research Category
Tags
Aslam Anis-Website Headshot-400x400
Aslam Anis
Senior Scientist, Health Economics, PhD, FCAHS

What did we do?

Execution of Research

AS (short for ‘ankylosing spondylitis’) is a severe form of spondyloarthritis (that affects the back, hips, and often other parts of the body. Specialist doctors have developed recommendations for how to care for AS patients, which include how to use medications, physiotherapy, and other treatments. However, these recommendations can be hard to understand – in fact, it is possible that different doctors will interpret the recommendations in different ways. For researchers who want to study the effect of following recommended care, it is important to understand exactly what is recommended and how to tell if AS care is being given as directed. To help understand this, researchers brought together specialist doctors to talk about what the recommendations mean to them. The researchers then did an online survey to ask specialists what it means to follow AS care recommendations.

How Can People Get Involved?

Involvement

This study was led by a student researcher as part of a PhD thesis. A total of 7 researchers participated in the study.

Related Publications

Harvard S, Gossec L, Pham T, Richette P, Dougados M, Anis A, Fautrel B. Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies. Joint Bone Spine. 2016 Jan;83(1):101-3.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More